Morphine Sulfate XR Liposome Injection Articles
SkyePharma Inc changes name to Pacira
2 July 2007
A turnaround for SkyePharma with injectables unit sale for $82M
15 January 2007
SkyePharma's 1st-half 2006 loss doubles
9 October 2006
SkyePharma reviews options as no buyer found
13 February 2006
SkyePharma's DepoDur available in the USA
13 December 2004
SkyePharma sees net loss fall for 1st-half 2004, as sales rise and R&D costs decrease
20 September 2004
Endo Pharma sees 2nd-qtr profits slump
26 July 2004
SkyePharma enters alliance with Vectura
7 June 2004
Stock Commentary - Europe
31 May 2004
FDA OKs SkyePharma's DepoDur
24 May 2004
Showing 1-10 of 10 articles
- 1
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
